Brian Feroldi

Brian Feroldi


Brian Feroldi has been covering the healthcare and technology industries for the Motley Fool since 2015. Brian's investing goal is to find the highest quality companies that he can find, buy them, and then to sit back and let compounding work its magic. See all of his articles here and make sure you follow him on Twitter.

Recent articles

Synopsys' Growth Accelerates

The semiconductor software specialist raises its full-year guidance again after another strong quarter.

To Tesla or Not to Tesla?

A bull and a bear walk into a room and (civilly!) talk about the most controversial stock on the market.

Infinera Benefits From Coriant Acquisition

The company's numbers in its latest report weren't great in absolute terms, but the pipeline continues to grow and management believes that it's on pace to return to profitability by the end of the year.

New Relic Experiences Growing Pains

Product launches are putting stress on the organization and have caused a few of the company's key metrics to slip.